These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 8596758

  • 21. Genetic predisposition for development of nephropathy in type 2 diabetes mellitus.
    Kumar R, Sharma RK, Agarwal S.
    Biochem Genet; 2013 Dec; 51(11-12):865-75. PubMed ID: 23846111
    [Abstract] [Full Text] [Related]

  • 22. Relationships between angiotensin I converting enzyme gene polymorphism and renal complications in Korean IDDM patients.
    Oh TG, Shin CS, Park KS, Kim SY, Cho BY, Lee HK, Koh CS.
    Korean J Intern Med; 1996 Jun; 11(2):133-7. PubMed ID: 8854649
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients.
    Park HC, Choi SR, Kim BS, Lee TH, Kang BS, Choi KH, Lee HY, Han DS, Ha SK.
    Yonsei Med J; 2005 Dec 31; 46(6):779-87. PubMed ID: 16385653
    [Abstract] [Full Text] [Related]

  • 25. [Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].
    Krajina-Andricević M, Zibar L, Glavas-Obrovac- L, Stefanić M, Avdicević M, Barbić J.
    Acta Med Croatica; 2011 Oct 31; 65 Suppl 3():14-9. PubMed ID: 23120809
    [Abstract] [Full Text] [Related]

  • 26. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM.
    Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M.
    Diabetologia; 1996 Jan 31; 39(1):97-102. PubMed ID: 8720609
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, Kaider A, Prager R, Abrahamian H, Irsigler K, Mayer G.
    Diabetologia; 1997 Mar 31; 40(3):327-31. PubMed ID: 9084972
    [Abstract] [Full Text] [Related]

  • 28. Polymorphism of the angiotensin I-converting enzyme gene in diabetic nephropathy in type II diabetic patients with proliferative retinopathy.
    Hanyu O, Hanawa H, Nakagawa O, Tani N, Andou N, Aizawa Y, Shibata A.
    Ren Fail; 1998 Jan 31; 20(1):125-33. PubMed ID: 9509566
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients.
    Hadjadj S, Gallois Y, Alhenc-Gelas F, Chatellier G, Marre M, Genes N, Lievre M, Mann J, Menard J, Vasmant D, DIABHYCAR Study Group.
    Diabet Med; 2003 Aug 31; 20(8):677-82. PubMed ID: 12873298
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy.
    Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, Fukuda M, Ogihara T.
    Diabetologia; 1998 Jan 31; 41(1):47-53. PubMed ID: 9498629
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients.
    Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, Ramachandran A, Jayaraman M, Sharma K.
    JOP; 2001 Mar 31; 2(2):83-7. PubMed ID: 11867868
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Association between ACE gene polymorphism and therapeutic responsiveness of ACEI in diabetic nephropathy].
    Wang L, Pan CY, Hu W.
    Zhonghua Yi Xue Za Zhi; 1998 May 31; 78(5):372-4. PubMed ID: 10923445
    [Abstract] [Full Text] [Related]

  • 39. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.
    BMJ; 1996 Sep 07; 313(7057):591-4. PubMed ID: 8806248
    [Abstract] [Full Text] [Related]

  • 40. Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population.
    Al-Harbi EM, Farid EM, Gumaa KA, Masuadi EM, Singh J.
    Mol Cell Biochem; 2011 Apr 07; 350(1-2):119-25. PubMed ID: 21207118
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.